Clinical Trials Directory

Trials / Completed

CompletedNCT02222285

An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Enzymotec · Industry
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The primary study objective is to evaluate the efficacy of Vayarin\_005 on ASD related symptoms in children.

Conditions

Interventions

TypeNameDescription
OTHERMedical Food : Vayarin_005
OTHERPlacebo

Timeline

Start date
2014-08-01
Primary completion
2017-05-01
Completion
2017-10-01
First posted
2014-08-21
Last updated
2018-04-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02222285. Inclusion in this directory is not an endorsement.

An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Diso (NCT02222285) · Clinical Trials Directory